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Question: How to order and interpret iron studies for a hospitalized patient with anemia? 
 
 
Answer: Anemia is defined as a hemoglobin 
<13.5 g/dL in men and <12.0 g/dL in 
women. Iron deficiency anemia (IDA) has 
been historically considered as a 
hemodynamically stable anemia that could 
be referred to outpatient clinics; therefore, it 
is often underdiagnosed in an inpatient 
setting. Sometimes, it is also missed even 
when iron studies were checked.  
Currently, there is no single test or a 
battery of tests to accurately diagnose IDA. 
Each test has its limitation. The cutoff for 
diagnosis often depends on a patient’s 
comorbidities. Physicians need to use their 
best knowledge to make a diagnosis.  
The most common iron studies are 
iron level, iron saturation, total iron-binding 
capacity (TIBC) and serum ferritin. The 
diagnosis of IDA is accepted based on the 
following: iron <11 umol/L, transferrin 
saturation (%Sat) <0.20, total iron-binding 
capacity (TIBC) >45 umol/L, and ferritin 
<13 ug/L for females and <25 ug/L for 
males.
1
 Using these criteria, one study 
reported iron deficiency was correctly 
diagnosed by serum iron in 41%, %Sat in 
50%, TIBC in 84%, and ferritin in 90% of 
the patients.
1
 The sensitivity and specificity 
for each test were as follows: iron level 
(77.5%, 35.6%), %Sat (76.5%, 45.6%), 
TIBC (55.9%, 87.3%), ferritin (52.5%, 
95%)
1
. Therefore, serum ferritin could be 
the most useful, especially in uncomplicated 
patients. However, it is less sensitive. The 
diagnosis of iron deficiency can usually be 
made based on serum ferritin ≤15 ug/L 
alone or serum ferritin along with the rest of 
iron studies for higher sensitivity. On the 
contrary, a low serum iron cannot be used to 
diagnose iron deficiency because iron may 
also be low in anemia of chronic disease.  
Ferritin is often nonspecifically 
elevated by inflammation, liver disease, 
heart failure, and malignancy regardless of 
iron stores. The cutoff value for serum 
ferritin should be increased in patients with 
comorbidities. In some specific populations, 
such as veterans with concomitant medical 
problems, a serum ferritin level ≤100 ug/L 
was optimal for determining iron 
deficiency.
2
 A ferritin level of ≤50 ug/L 
would be used as evidence of iron 
deficiency in patients with inflammation or 
malignancy.
2
 C-reactive protein (CRP), 
erythrocyte sedimentation rate (ESR), and 
erythropoietin (EPO) could also be ordered 
in patients with comorbidities. 
IDA is also predicted by low mean 
corpuscular volume (MCV)
3
, wide red cell 
distribution width (RDW), low reticulocyte 
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count, and reactive thrombocytosis.
4
 Low 
MCV sometimes might be overlapped with 
macrocytic anemia resulting in a normal 
MCV
3
.  Reactive thrombocytosis is a good 
predictor. It appears in 31% of patients with 
IDA and resolves in 66% of patients 28 days 
after treatment.
4
 Additionally, a peripheral 
blood smear could also be ordered and a 
pathology review would be requested. 
Importantly, iron studies should 
always be performed before blood 
transfusion. A typical blood transfusion has 
been shown to raise serum iron level 
and %Sat during the first 24 hours, which 
persisted at a marginally significant level up 
to 36 hours.
5
 However, no significant 
changes of TIBC and ferritin levels have 
been noted.
5-6
 
When confronting inconclusive 
initial testing or comorbidities, physicians 
should consult a hematologist while the 
patient is in the hospital. The most reliable 
means of diagnosing IDA is to evaluate iron 
storage in the bone marrow.
1
 It is sensitive 
and specific. However, it is invasive, 
uncomfortable, and expensive; hence, it 
should always be determined by a 
hematologist and it is usually used as an 
approach to diagnose hematologic diseases 
other than IDA. 
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